Reduction of steroid-induced intraocular pressure elevation in sheep by tissue plasminogen activator
- PMID: 24176900
- PMCID: PMC3850667
- DOI: 10.1167/iovs.13-12801
Reduction of steroid-induced intraocular pressure elevation in sheep by tissue plasminogen activator
Abstract
Purpose: To investigate whether tissue plasminogen activator (tPA) can prevent and/or reverse steroid-induced IOP elevation in an ovine model.
Methods: Three animal groups were subjected to bilateral steroid-induced IOP elevation using thrice daily topical ocular prednisolone administration. In the first group (N = 8), one eye each of two sheep was injected intravitreally with 100 μg, 200 μg, 500 μg, or 1 mg human recombinant tPA, while contralateral eyes received vehicle. In the second group (N = 2), one eye was injected intravitreally with tPA (100 μg), while contralateral eyes received vehicle containing L-arginine. In the third group (N = 4), each animal received intravitreal tPA in one eye concurrently with initiation of bilateral steroid administration. IOP was monitored for the duration of the experiment. Tissues from eyes of the third group were used to determine relative gene expression.
Results: In the first and second groups, IOP decreased by 9.7 (±2.8) and 9.7 (±1.6) mm Hg, respectively, 24 hours after tPA administration. In the third group, tPA-treated eyes did not develop IOP elevation with ΔIOP of 11.8 (±1.3) mm Hg 8 days later. In all tPA-treated eyes, IOP remained low until the end of the study. mRNA levels in the trabecular meshwork were decreased for plasminogen activator tissue (PLAT), increased for matrix-metalloproteinase 1 (MMP-1), and stable for plasminogen activator inhibitor 1 (PAI-1), MMP-2, MMP-9, and MMP-13 in tPA-treated eyes compared with contralateral controls. PAI-1 mRNA levels in ciliary processes also remained similar.
Conclusions: Recombinant human tPA is effective in both preventing and reversing steroid-induced IOP elevation in sheep. Tissue plasminogen activator may be useful as a therapeutic agent in steroid-induced glaucoma.
Keywords: extracellular matrix; intraocular pressure; matrix metalloproteinase; tissue plasminogen activator; trabecular meshwork.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3850667/bin/i1552-5783-54-13-7903-f01.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3850667/bin/i1552-5783-54-13-7903-f02.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3850667/bin/i1552-5783-54-13-7903-f03.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3850667/bin/i1552-5783-54-13-7903-f04.gif)
Similar articles
-
Tissue plasminogen activator reduces the elevated intraocular pressure induced by prednisolone in sheep.Exp Eye Res. 2014 Nov;128:114-6. doi: 10.1016/j.exer.2014.10.004. Epub 2014 Oct 7. Exp Eye Res. 2014. PMID: 25304217 Free PMC article.
-
Tissue plasminogen activator attenuates outflow facility reduction in mouse model of juvenile open angle glaucoma.Exp Eye Res. 2020 Oct;199:108179. doi: 10.1016/j.exer.2020.108179. Epub 2020 Jul 31. Exp Eye Res. 2020. PMID: 32739292
-
Tissue plasminogen activator in trabecular meshwork attenuates steroid induced outflow resistance in mice.PLoS One. 2013 Aug 19;8(8):e72447. doi: 10.1371/journal.pone.0072447. eCollection 2013. PLoS One. 2013. PMID: 23977299 Free PMC article.
-
Model systems for the study of steroid-induced IOP elevation.Exp Eye Res. 2017 May;158:51-58. doi: 10.1016/j.exer.2016.07.013. Epub 2016 Jul 20. Exp Eye Res. 2017. PMID: 27450911 Free PMC article. Review.
-
Steroid-induced iatrogenic glaucoma.Ophthalmic Res. 2012;47(2):66-80. doi: 10.1159/000328630. Epub 2011 Jul 13. Ophthalmic Res. 2012. PMID: 21757964 Review.
Cited by
-
Glucocorticoid-Induced Ocular Hypertension and Glaucoma.Clin Ophthalmol. 2024 Feb 16;18:481-505. doi: 10.2147/OPTH.S442749. eCollection 2024. Clin Ophthalmol. 2024. PMID: 38379915 Free PMC article. Review.
-
Glucocorticoid-Induced Ocular Hypertension: Origins and New Approaches to Minimize.Expert Rev Ophthalmol. 2020;15(3):145-157. doi: 10.1080/17469899.2020.1762488. Epub 2020 May 14. Expert Rev Ophthalmol. 2020. PMID: 38274668 Free PMC article.
-
Role of Glucocorticoids and Glucocorticoid Receptors in Glaucoma Pathogenesis.Cells. 2023 Oct 14;12(20):2452. doi: 10.3390/cells12202452. Cells. 2023. PMID: 37887296 Free PMC article. Review.
-
Molecular Mechanism and Role of Japanese Encephalitis Virus Infection in Central Nervous System-Mediated Diseases.Viruses. 2022 Nov 30;14(12):2686. doi: 10.3390/v14122686. Viruses. 2022. PMID: 36560690 Free PMC article. Review.
-
Relationships between Intraocular Pressure, Effective Filtration Area, and Morphological Changes in the Trabecular Meshwork of Steroid-Induced Ocular Hypertensive Mouse Eyes.Int J Mol Sci. 2022 Jan 13;23(2):854. doi: 10.3390/ijms23020854. Int J Mol Sci. 2022. PMID: 35055036 Free PMC article.
References
-
- Lijnen HR, Collen D. Mechanisms of physiological fibrinolysis. Baillieres Clin Haematol. 1995; 8: 277–290 - PubMed
-
- Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 1990; 6: 121–125 - PubMed
-
- Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds JJ. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann N Y Acad Sci. 1992; 667: 1–12 - PubMed
-
- Bradley JM, Vranka J, Colvis CM, et al. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci. 1998; 39: 2649–2658 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous